Insights into Adeno-Associated Virus Capsid Charge Heterogeneity
Jiaqi Wu1, Benjamin E Draper2, Martin F Jarrold2
1ProteinSimple, a Bio-Techne Brand, 3001 Orchard Parkway, San Jose, California 95134, United States.
This study details a workflow to analyze Adeno-associated virus (AAV) charge heterogeneity. It identifies capsid protein ratios, deamidation, and ssDNA content as key contributors to AAV charge differences.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Adeno-associated viruses (AAVs) are crucial gene therapy vectors.
- Understanding AAV charge heterogeneity is vital for vector quality control and efficacy.
- Existing methods often lack the resolution to dissect multiple contributing factors simultaneously.
Purpose of the Study:
- To develop and validate a comprehensive workflow for analyzing AAV charge heterogeneity.
- To identify and quantify the contributions of capsid protein composition, post-translational modifications, and packaged DNA to AAV charge variants.
- To provide a deeper understanding of the factors driving AAV capsid heterogeneity.
Main Methods:
- Imaged capillary isoelectric focusing (icIEF)-based fractionation of intact AAV9 capsids.
- Analytical icIEF and charge detection mass spectrometry (CD-MS) for capsid integrity assessment.
- Capillary electrophoresis (CE) immunoassays for capsid protein ratio and deamidation analysis.
- CE-immunoassay and high-resolution CD-MS for ssDNA content analysis.
Main Results:
- Successfully fractionated AAV9 capsids based on isoelectric points (pIs).
- Quantified capsid protein ratios and deamidation levels across different fractions.
- Characterized the ssDNA content within each capsid fraction.
- Demonstrated the distinct contributions of these factors to overall AAV charge heterogeneity.
Conclusions:
- The described workflow effectively dissects multiple contributors to AAV charge heterogeneity from a single sample.
- This methodology enhances the characterization of AAV vector quality.
- Provides critical insights for optimizing AAV production and therapeutic applications.
More Related Videos
09:12Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
Published on: April 5, 2024
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
Related Concept Videos
Viral Structure
Size and Structure of Viral Genomes
